KMID : 1140220210260010032
|
|
´ëÇѾϿ¹¹æÇÐȸÁö 2021 Volume.26 No. 1 p.32 ~ p.40
|
|
Dysregulated Free Fatty Acid Receptor 2 Exacerbates Colonic Adenoma Formation in ApcMin/+ Mice: Relation to Metabolism and Gut Microbiota Composition
|
|
Huang Yi-Wen
Lin Chien-Wei Pan Pan Echeveste Carla Elena Dong Athena Oshima Kiyoko Yearsley Martha Yu Jianhua Wang Li-Shu
|
|
Abstract
|
|
|
Free fatty acid receptor 2 (FFAR2) has been reported as a tumor suppressor in colon cancer development. The current study investigated the effects of FFAR2 signaling on energy metabolism and gut microbiota profiling in a colorectal cancer mouse model (ApcMin/+). Ffar2 deficiency promoted colonic polyp development and enhanced fatty acid oxidation and bile acid metabolism. Gut microbiome sequencing analysis showed distinct clustering among wild-type, ApcMin/+, and ApcMin/+-Ffar2-/- mice. The relative abundance of Flavobacteriaceae and Verrucomicrobiaceae was significantly increased in the ApcMin/+-Ffar2-/- mice compared to the ApcMin/+ mice. In addition, knocking-down FFAR2 in the human colon cancer cell lines (SW480 and HT29) resulted in increased expression of several key enzymes in fatty acid oxidation, such as carnitine palmitoyltransferase 2, acyl-CoA dehydrogenase, longchain acyl-CoA dehydrogenase, C-2 to C-3 short chain, and hydroxyacyl-CoA dehydrogenase/3-ketoacyl-CoA thiolase/enoyl-CoA hydratase, alpha subunit. Collectively, these results demonstrated that Ffar2 deficiency significantly altered profiles of fatty acid metabolites and gut microbiome, which might promote colorectal cancer development.
|
|
KEYWORD
|
|
Ffar2, ApcMin/+, Colorectal cancer, Metabolomics, Gut microbiota
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|